HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Nikola (NKLA) Investors with $200k+ Losses to Contact Its Attorneys, Securities Fraud Case Filed, SEC & DOJ Reportedly Investigating
Hagens Berman urges Nikola Corporation investors to contact the firm now. A securities fraud class action lawsuit has been filed. Class Period: Mar. 3, 2020 – Sept. 15, 2020Lead Plaintiff Deadline: Nov. 16, 2020Visit: www.hbsslaw.com/investor-fraud/NKLAContact An Attorney Now: NKLA@hbsslaw.com844-916-0895 Nikola Corporation (NKLA) Securities Class Action The Complaint alleges that throughout the Class Period, Defendants falsely stated or omitted that: (1) VectoIQ … Continue reading HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Nikola (NKLA) Investors with $200k+ Losses to Contact Its Attorneys, Securities Fraud Case Filed, SEC & DOJ Reportedly Investigating Continue Reading


WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Monocle Acquisition Corporation, a special purpose acquisition company, in connection with the Company’s proposed merger with privately-held AerSale Corp. (“AerSale”). Upon completion of the merger and assuming no public stockholders exercise their redemption rights, MNCL stockholders …
Alamos Gold Inc. reported new results from surface exploration drilling at the Island Gold Mine, further extending high-grade gold mineralization down-plunge in Island East. All reported drill widths are true width of the mineralized zones, unless otherwise stated. “These new high-grade results over much greater widths include the best surface exploration hole ever drilled at Island …
Pipestone Energy Corp. (“Pipestone Energy” or the “Company”) is pleased to announce that following receipt of overwhelming approval at the annual and special meeting of the shareholders of Pipestone Energy held on September 14, 2020 (the “Shareholder Meeting”), it has closed the previously announced financing (the “Financing”) pursuant to subscription agreements with Riverstone V EMEA …
Trillium Therapeutics Inc., a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced the appointment of pharmaceutical industry leader Michael Kamarck, Ph.D., to its Board of Directors, effective immediately. “We are excited to welcome Dr. Kamarck to the board of directors,” said Robert L. Kirkman, M.D., Chair of Trillium Therapeutics. “His …